202 related articles for article (PubMed ID: 17908996)
1. A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9.
O'Neill GM; Seo S; Serebriiskii IG; Lessin SR; Golemis EA
Cancer Res; 2007 Oct; 67(19):8975-9. PubMed ID: 17908996
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle.
Singh M; Cowell L; Seo S; O'Neill G; Golemis E
Cell Biochem Biophys; 2007; 48(1):54-72. PubMed ID: 17703068
[TBL] [Abstract][Full Text] [Related]
3. Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity.
Bui LC; Tomkiewicz C; Chevallier A; Pierre S; Bats AS; Mota S; Raingeaud J; Pierre J; Diry M; Transy C; Garlatti M; Barouki R; Coumoul X
Oncogene; 2009 Oct; 28(41):3642-51. PubMed ID: 19648964
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of human enhancer filamentation 1 (HEF1) stimulates interaction with Polo-like kinase 1 leading to HEF1 localization to focal adhesions.
Lee KH; Hwang JA; Kim SO; Kim JH; Shin SC; Kim EE; Lee KS; Rhee K; Jeon BH; Bang JK; Cha-Molstad H; Soung NK; Jang JH; Ko SK; Lee HG; Ahn JS; Kwon YT; Kim BY
J Biol Chem; 2018 Jan; 293(3):847-862. PubMed ID: 29191835
[TBL] [Abstract][Full Text] [Related]
5. NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
Speranza MC; Frattini V; Pisati F; Kapetis D; Porrati P; Eoli M; Pellegatta S; Finocchiaro G
Oncotarget; 2012 Jul; 3(7):723-34. PubMed ID: 22869051
[TBL] [Abstract][Full Text] [Related]
6. Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.
Shagisultanova E; Gaponova AV; Gabbasov R; Nicolas E; Golemis EA
Gene; 2015 Aug; 567(1):1-11. PubMed ID: 25967390
[TBL] [Abstract][Full Text] [Related]
7. The metastasis gene NEDD9 product acts through integrin β3 and Src to promote mesenchymal motility and inhibit amoeboid motility.
Ahn J; Sanz-Moreno V; Marshall CJ
J Cell Sci; 2012 Apr; 125(Pt 7):1814-26. PubMed ID: 22328516
[TBL] [Abstract][Full Text] [Related]
8. Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent.
Lucas JT; Salimath BP; Slomiany MG; Rosenzweig SA
Oncogene; 2010 Aug; 29(31):4449-59. PubMed ID: 20498643
[TBL] [Abstract][Full Text] [Related]
9. HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells.
Xia D; Holla VR; Wang D; Menter DG; DuBois RN
Cancer Res; 2010 Jan; 70(2):824-31. PubMed ID: 20068165
[TBL] [Abstract][Full Text] [Related]
10. NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis.
McLaughlin SL; Ice RJ; Rajulapati A; Kozyulina PY; Livengood RH; Kozyreva VK; Loskutov YV; Culp MV; Weed SA; Ivanov AV; Pugacheva EN
Mol Cancer Res; 2014 Jan; 12(1):69-81. PubMed ID: 24202705
[TBL] [Abstract][Full Text] [Related]
11. Roles of neural precursor cell expressed, developmentally downregulated 9 in tumor-associated cellular processes (Review).
Zhang S; Wu L
Mol Med Rep; 2015 Nov; 12(5):6415-21. PubMed ID: 26324022
[TBL] [Abstract][Full Text] [Related]
12. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
Jones BC; Kelley LC; Loskutov YV; Marinak KM; Kozyreva VK; Smolkin MB; Pugacheva EN
Mol Cancer Res; 2017 Jun; 15(6):670-682. PubMed ID: 28235899
[TBL] [Abstract][Full Text] [Related]
13. Role for chondroitin sulfate glycosaminoglycan in NEDD9-mediated breast cancer cell growth.
Iida J; Dorchak J; Clancy R; Slavik J; Ellsworth R; Katagiri Y; Pugacheva EN; van Kuppevelt TH; Mural RJ; Cutler ML; Shriver CD
Exp Cell Res; 2015 Jan; 330(2):358-370. PubMed ID: 25445787
[TBL] [Abstract][Full Text] [Related]
14. NEDD9 and BCAR1 negatively regulate E-cadherin membrane localization, and promote E-cadherin degradation.
Tikhmyanova N; Golemis EA
PLoS One; 2011; 6(7):e22102. PubMed ID: 21765937
[TBL] [Abstract][Full Text] [Related]
15. siRNA Suppression of NEDD9 Inhibits Proliferation and Enhances Apoptosis in Renal Cell Carcinoma.
Wang J; Yang WJ; Sun C; Luan Y; Cheng GH; Li KL; Kong F
Oncol Res; 2014; 22(4):219-224. PubMed ID: 26351211
[TBL] [Abstract][Full Text] [Related]
16. A novel large regulator RNA, B2, partially overlaps the HEF1/NEDD9/Cas-L gene.
Malleter M; Jacquot C; Moreau D; Tomasoni C; Tsvetanova M; Chinou I; Juge M; Pineau A; Le Pape P; Roussakis C
Int J Mol Med; 2010 Jun; 25(6):897-903. PubMed ID: 20428794
[TBL] [Abstract][Full Text] [Related]
17. NEDD9 promotes lung cancer metastasis through epithelial-mesenchymal transition.
Jin Y; Li F; Zheng C; Wang Y; Fang Z; Guo C; Wang X; Liu H; Deng L; Li C; Wang H; Chen H; Feng Y; Ji H
Int J Cancer; 2014 May; 134(10):2294-304. PubMed ID: 24174333
[TBL] [Abstract][Full Text] [Related]
18. CAS proteins in normal and pathological cell growth control.
Tikhmyanova N; Little JL; Golemis EA
Cell Mol Life Sci; 2010 Apr; 67(7):1025-48. PubMed ID: 19937461
[TBL] [Abstract][Full Text] [Related]
19. The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma.
Iizuka S; Abdullah C; Buschman MD; Diaz B; Courtneidge SA
Oncotarget; 2016 Nov; 7(48):78473-78486. PubMed ID: 27802184
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells.
Dai J; Van Wie PG; Fai LY; Kim D; Wang L; Poyil P; Luo J; Zhang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():106-112. PubMed ID: 27664007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
